10 authorised products containing Human normal immunoglobulin, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| CUTAQUIG, 165 mg/ml, solution for injection PA2219/001/001 |
Human normal immunoglobulin | Octapharma (IP) | Not marketed |
| Cuvitru 200 mg/ml solution for subcutaneous injection PA2004/008/001 |
Human normal immunoglobulin | Baxalta Innovations GmbH | Marketed |
| Flebogamma EU/1/07/404/1-5 |
Human normal immunoglobulin | Instituto Grifols S.A. | — |
| Flebogamma DIF EU/1/07/404/006-008 |
Human normal immunoglobulin | Instituto Grifols S.A. | — |
| Hizentra 200 mg/ml solution for subcutaneous injection EU/1/11/687/001-12 |
Human normal immunoglobulin | CSL Behring GmbH | — |
| HyQvia 100 mg/mL solution for infusion for subcutaneous use EU/1/13/840/001-006 |
Human normal immunoglobulin | Baxalta Innovations GmbH | — |
| Kiovig 100 mg/ml solution for infusion EU/1/05/329/001-006 |
Human normal immunoglobulin | Baxter AG | — |
| Panzyga, 100 mg/ml solution for infusion PA2219/010/001 |
Human normal immunoglobulin | Octapharma (IP) | Not marketed |
| Privigen 100 mg/ml solution for infusion EU/1/08/446/1-3 |
Human normal immunoglobulin | CSL Behring GmbH | — |
| Yimmugo PA0592/009/001 |
Human normal immunoglobulin | Biotest Pharma GmbH | Not marketed |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.